BRIEF published on 05/23/2024 at 09:17, 1 year 8 months ago Heidelberg Pharma participera et présentera des conférences scientifiques de premier plan à venir en mai et juin 2024 Conférences Traitement Du Cancer Heidelberg Pharma HDP-101 ADC
PRESS RELEASE published on 05/23/2024 at 09:12, 1 year 8 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 1 year 9 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
BRIEF published on 04/25/2024 at 07:26, 1 year 9 months ago Heidelberg Pharma AG publie ses résultats financiers et ses progrès opérationnels pour le premier trimestre 2024 Performance Financière Nomination Du PDG Heidelberg Pharma SA Essai Clinique HDP-101 Développement Du Pipeline ADC
PRESS RELEASE published on 04/25/2024 at 07:21, 1 year 9 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
BRIEF published on 04/05/2024 at 09:35, 1 year 10 months ago Heidelberg Pharma to Convene R&D Webinar to Share New Cancer Research Insights Heidelberg Pharma HDP-101 Multiple Myeloma ADCs R&D Webinar
BRIEF published on 04/05/2024 at 09:35, 1 year 10 months ago Heidelberg Pharma organisera un webinaire R&D pour partager de nouvelles informations sur la recherche sur le cancer Heidelberg Pharma HDP-101 Myélome Multiple ADC Webinaire R&D
PRESS RELEASE published on 04/05/2024 at 09:30, 1 year 10 months ago Heidelberg Pharma to host R&D Webinar following novel data presented at AACR Heidelberg Pharma AG to host R&D Webinar on 23 April 2024 featuring leading Key Opinion Leaders after presenting novel data at AACR. Event focuses on ADC technologies for cancer treatment Cancer Treatment Heidelberg Pharma AG R&D Webinar ADC Technologies AACR
BRIEF published on 03/27/2024 at 09:06, 1 year 10 months ago Heidelberg Pharma Obtains FDA Orphan Drug Designation for HDP-101 in Multiple Myeloma Treatment FDA Orphan Drug Designation Heidelberg Pharma HDP-101 Multiple Myeloma
BRIEF published on 03/27/2024 at 09:06, 1 year 10 months ago Heidelberg Pharma obtient la désignation de médicament orphelin par la FDA pour le HDP-101 dans le traitement du myélome multiple FDA Heidelberg Pharma Désignation De Médicament Orphelin HDP-101 Myélome Multiple
Published on 02/10/2026 at 13:30, 35 minutes ago Revival Gold Intercepts 1.0 g/t Gold Over 30 Meters and Extends Mineralization at Mercur Project in Utah
Published on 02/10/2026 at 13:30, 35 minutes ago Metallic Minerals Provides Keno Silver Project Update and Details 2026 Exploration Plans
Published on 02/10/2026 at 13:00, 1 hour 5 minutes ago Kalo Gold Advances 2026 Target Development at Vatu Aurum; Lidar and Orthophotography Completed; Airborne Geophysics Planned for February
Published on 02/10/2026 at 13:00, 1 hour 5 minutes ago NOA Lithium Announces Additional Warrant Exercises for $818,000
Published on 02/10/2026 at 13:00, 1 hour 5 minutes ago Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
Published on 02/10/2026 at 13:39, 26 minutes ago EQS-Adhoc: Salzgitter Aktiengesellschaft: Preliminary financials for the financial year 2025; Management Guidance 2026 approved
Published on 02/10/2026 at 13:39, 26 minutes ago Bernd Spalt fulfils current contract – but does not seek extension
Published on 02/10/2026 at 13:35, 30 minutes ago Bernd Spalt fulfils current contract – but does not seek extension
Published on 02/10/2026 at 13:15, 50 minutes ago SCOPE’s Ultra-Luxury Residential Performance Underscores Strong Investor Confidence in Thailand’s Prime Market
Published on 02/10/2026 at 13:08, 57 minutes ago Commerzbank exceeds profit target and launches further share buyback of up to €540m – dividend for 2025 to be €1.10 per share
Published on 02/09/2026 at 18:00, 20 hours 5 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 20 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 20 hours 20 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 20 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 20 minutes ago Déclaration des droits de vote à fin janvier 2026
